Bayforest Capital’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9K Buy
+320
New +$20.8K 0.03% 723
2025
Q4
Sell
-2,436
Closed -$68.5K 965
2025
Q3
$68.5K Sell
2,436
-4,044
-62% -$122K 0.03% 562
2025
Q2
$238K Buy
6,480
+1,620
+33% +$56K 0.1% 343
2025
Q1
$191K Buy
4,860
+1,604
+49% +$72.2K 0.08% 398
2024
Q4
$151K Buy
+3,256
New +$147K 0.19% 196

Other funds holding TWST

Bayforest Capital's TWST Position: Q2 2026 in Review

Bayforest Capital opened a new position in Twist Bioscience (TWST) in Q2 2026: 320 shares worth $32.9K. The stake represents 0.03% of the portfolio and ranks #723 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in TWST as recently as Q3 2025.

Bayforest Capital first reported a position in TWST in Q4 2024 and has held it in 5 quarters since. The position peaked at $238K in Q2 2025. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Bayforest Capital held 320 shares of Twist Bioscience worth $32.9K as of Q2 2026.
  • Twist Bioscience was a new Bayforest Capital position in Q2 2026.
  • Twist Bioscience made up 0.03% of Bayforest Capital's portfolio in Q2 2026, its #723 holding.
  • Bayforest Capital first reported a position in Twist Bioscience in Q4 2024 and has held it in 5 quarters since.
  • Bayforest Capital's Twist Bioscience position peaked at $238K in Q2 2025.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.